Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Patrick Cunningham

Citigroup · covers Basic Materials

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).

Questions
75on tracked calls
Challenge rate
9%7 of 75 questions
Companies
11questioned at least once
Reporting periods
8with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 75 of 75 questions from 11 companies

APDAir Products13 questions · 8 reporting periods · 2 of 13 challenging
APD company page →

Calendar 2026 Q2

you said that you were able to monetize something about $1 billion, I think. I'm just wondering if that still holds true

Capital AllocationCapex InvestmentTranscript · FY2026 Q3 →
Show response

Eduardo said prior Darrow monetization figures were estimates and declined a clear timeline, emphasizing value comes from selling the units as a whole; on Edmonton he offered no updates on start-up dates or costs.

Calendar 2026 Q1

could you provide an update on the Alberta project in terms of offtakes timing and any update to costs?

Capital AllocationRegulation PolicyTranscript · FY2026 Q2 →
Show response

Eduardo offered minimal detail. No updates on offtakes or costs. Working with Canadian federal and provincial governments on regulatory conditions.

If the supply disruption persists, would you need to put customers on allocation? How long does it take alternative supply sources

ChallengingSupply ChainDemandTranscript · FY2026 Q2 →
Show response

Eduardo noted Qatar supply was already offline since December so conflict did not materially change the supply situation. Company has enough product for customers.

Calendar 2025 Q4

Is there any dependency on the relationship with Yara at Darrow. And are these go, no go decisions being viewed separately?

Capex InvestmentRegulation PolicyTranscript · FY2026 Q1 →
Show response

Eduardo confirmed NEOM and Louisiana negotiations are independent. NEOM product is green with zero CBAM impact. Any CBAM changes would only have indirect market effects.

should we expect that to be at a loss when the asset first ramps up given the debt profile and initial fixed cost burden?

Capex InvestmentMarginTranscript · FY2026 Q1 →
Show response

Management confirmed NEOM JV will not start at a loss but declined to disclose specific expected equity affiliate contributions from the 33%-owned venture.

Calendar 2025 Q3

Can you provide some color on what was driving that and what we should sort of expect for step up or step down across all of the regions and equity income next year?

Geographic ExpansionMarginTranscript · FY2025 Q4 →
Show response

Melissa attributed Americas growth to Mexican JV (expected flat in FY2026). Jazan JV declined in FY2025 but expected to pick up in FY2026 as interest rates decline.

If you decide to forgo downstream investment in NEOM maybe based on unfavorable regulatory environment, whatever it may be, what do the commercial options look like?

Capex InvestmentDemandTranscript · FY2025 Q4 →
Show response

Eduardo acknowledged initial sales will be as ammonia with green premium percentage growing over time. Full 2027 forecast not available yet given ammonia market pricing dynamics.

Calendar 2025 Q2

Does this change the dynamic at all for Air Products? I know you mentioned Darrow is cost competitive, but are there now fewer logical equity partners

Competitive DynamicsCapex InvestmentTranscript · FY2025 Q3 →
Show response

Eduardo sees room for APD's project alongside competitors, noting increasing clean ammonia demand from Far East power producers and European market potential.

Calendar 2025 Q1

you're now delaying the downstream investment until you get regulatory clarity - what does that mean for the agreement with Total?

ChallengingRegulation PolicyCapex InvestmentTranscript · FY2025 Q2 →
Show response

Eduardo clarified Total agreement is for 2030, with ongoing engineering and permitting work. By 2027, expects definition on which refinery to supply based on country-level EU regulation transposition.

What's your sense for the opportunity on productivity and price optimization for the core business? How meaningful will those levers be?

Show response

Eduardo expressed confidence in raising operating margins to 30% through blocking and tackling, noting base business at 24% with room for improvement.

Calendar 2024 Q4

I'm just wondering what your latest thoughts are there. Any conversations with customers suggesting this could be maybe a short-term negative to production

Trade TariffsMacroeconomicTranscript · FY2025 Q1 →
Show response

Melissa framed tariff risk as moderate for projects, minimal for core business given local production model, with main risk being macro knock-on effects to customers.

Calendar 2024 Q3

with the LNG out of the business, what should we expect in terms of the corporate line for 2025?

Show response

Melissa quantified LNG headwind precisely at $0.49 EPS or 4%, distributed evenly across quarters.

could you provide a more general update on the World Energy Project? What is holding up the permitting process?

Regulation PolicyCapex InvestmentTranscript · FY2024 Q4 →
Show response

Seifi explained permit was challenged by environmental groups despite being an environmentally friendly project. Decision to wait for full permits before proceeding.

DDDuPont9 questions · 5 reporting periods · 0 of 9 challenging
DD company page →

Calendar 2026 Q2

can you just expand maybe on which parts of the portfolio is maybe accelerating higher than others?

DemandRevenue GrowthTranscript · FY2026 Q2 →
Show response

Franzen detailed Building Tech up low-single-digit and Industrial Tech mid-single-digit with an improving order book.

Calendar 2026 Q1

You previously noted, I think, free cash flow greater than 90% for 2026. Is that still the case?

Capital AllocationTranscript · FY2026 Q1 →
Show response

Franzen confirmed >90% FCF conversion target intact. Q1 conversion was 65%, consistent with normal H1/H2 cadence (interest payments in Q2/Q4). Teams managing inventory days down YoY despite higher input costs. DSO collections also a focus.

I think this is the first time you kind of explicitly called out microelectronics within water

DemandInnovation & R&DTranscript · FY2026 Q1 →
Show response

Koch confirmed microelectronics is ~20% of ion exchange business within water. Seeing nice volume growth in Q1 driven by broader data center trend.

Calendar 2025 Q2

we should expect less of a drag from price in the second half?

Show response

Franzen confirmed price decline moderating as inflationary-era concessions are lapped, with volume-price trade-offs managed at line-of-business level.

Can you help us think about the margin progression for the second half given you've lapped the bulk of destocking

Show response

Franzen quantified 100bps underlying margin expansion (70bps reported) with IndustrialsCo incrementals at ~70% driven by productivity.

Calendar 2025 Q1

do you see any pressure on that outperformance, whether it's additional competitive dynamics, or changes with customer relationships

Competitive DynamicsCloud & AITranscript · FY2025 Q1 →
Show response

Kemp argued competitive moat from application engineering support and quality requirements as process complexity increases.

could fresh restrictions be a potential retaliatory measure in this trade environment?

Trade TariffsRegulation PolicyTranscript · FY2025 Q1 →
Show response

Kemp acknowledged the possibility but noted no specific anticipated restrictions, citing DuPont's track record of navigating since 2019.

Calendar 2024 Q4

is there any update on Kalrez? How is that business performing? We had a few quarters of sharp destocking

DemandSupply ChainTranscript · FY2024 Q4 →
Show response

Koch directly identified Kalrez as the last business still in destocking, targeting mid-2025 for normalization.

would you characterize these as normal levels? And does it change maybe what the long-term margin target would be for the IndustrialsCo versus W&P?

Show response

Koch acknowledged retained businesses have high-teens to low-20s margins, below heritage W&P levels, with more detail deferred to Investor Day.

ALBAlbemarle Corporation7 questions · 4 reporting periods · 1 of 7 challenging
ALB company page →

Calendar 2026 Q2

curious to hear kind of your latest thoughts on the supply side of the equation

DemandPricingCapex InvestmentTranscript · FY2026 Q2 →
Show response

Kent said demand is running ahead of supply, keeping the market tight, but current roughly $20/kg pricing is not driving speculative new projects.

Calendar 2026 Q1

you seem to hint the broader deployment of renewables as a result of the crisis could be a potential positive for lithium demand. I guess, is that anything that you've seen already?

DemandRegulation PolicyTranscript · FY2026 Q1 →
Show response

Masters said energy security and grid resiliency are bigger drivers globally. Difficult to attribute incremental demand directly to the Middle East crisis, but it may impact both EVs and energy storage.

one of your JV partners noted some issues around grade recoveries and production stability, maybe even suggesting that they're more systemic. I guess, is this in line with your assessment?

ChallengingSupply ChainCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Masters said the mine is on plan including CGP3 ramp. They risk-adjust annual forecasts across all assets. CGP3 started up end of 2025 and the ramp is on schedule.

Calendar 2025 Q3

How have sort of the bromine supply and demand trended throughout the balance of the year?

Show response

Norris described mixed bromine demand with electronics/pharma strong but construction/oil-gas weak. Market is fairly balanced heading into year-end.

anything else you're looking at in terms of productivity savings program into next year? And what would be the size of sort of the incremental carryover?

Cost PressureMarginTranscript · FY2025 Q3 →
Show response

Sheorey noted partial-year savings from 2025 will roll into 2026 with full-year benefit. Plant ramps like Meishan (a year ahead of schedule) provide ongoing productivity.

Calendar 2024 Q4

That remaining 50% piece not on long-term agreements, should we assume most of those follow spot mechanisms?

PricingCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Masters confirmed the non-floor 50% is essentially at spot/index pricing and noted no recent renegotiations of floor contracts.

where are you cutting back investments in resources? And given the current program, how quickly can you repossession and invest in additional brownfield

Capex InvestmentRevenue GrowthTranscript · FY2024 Q4 →
Show response

Masters clarified most CapEx cuts were in conversion, not resources. Acknowledged growth rates will slow after 2027, mostly due to resource constraints.

LYBLyondellBasell7 questions · 7 reporting periods · 2 of 7 challenging
LYB company page →

Calendar 2026 Q2

I wanted to dig into a little bit more on supply disruption. I think the ability for China to sell out of inventory

Supply ChainInventoryTranscript · FY2026 Q2 →
Show response

Vanacker said China structurally adapted (more coal-to-olefins, higher exports) but that the inventory drawdowns are temporary and China should return to importing.

Calendar 2026 Q1

if you could walk through any of the structural changes you've seen from a cost curve and supply and demand standpoint given the conflict

MarginCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Aaron detailed pricing power across all I&D products: methanol doubled from $300 to $600/ton in 3 months, acid pricing up 50%, VAM up 100%. US natural gas pricing lowest across all regions giving cost advantage. Both PO technologies in first quartile of cost curve. Running 75% Q2 utilization due to Bayport outage, expects 95-100% once Bayport returns.

Calendar 2025 Q4

if the reduced CapEx guide is a function of just recent asset sales or if there's a change in your maintenance CapEx or if the new $800 million on maintenance is the normal baseline

Capex InvestmentCapital AllocationTranscript · FY2025 Q4 →
Show response

Peter explained $800M maintenance CapEx is not the new normal, historical sustaining CapEx was $1.2B, expected to settle at ~$1.1B post-European asset sale. Only 2 turnarounds in 2026 vs typical 3-4 per year. Years of above-depreciation investment enable lighter 2026 spending. Agustin confirmed light turnaround year with only Midwest and smaller IND turnaround.

Calendar 2025 Q3

how would you weight the likelihood of any sort of inflection point in supply and demand or underlying prices and margins into next year

Competitive DynamicsPricingTranscript · FY2025 Q3 →
Show response

Peter cited 21M tonnes of ethylene capacity expected to close, noting much Chinese capacity is on wrong side of cash cost curve. Emphasized need to look at economically feasible capacity, not just nameplate. Kim added new derivative capacity coming online will tighten ethylene markets and improve chain margins into 2026. Peter noted oil-to-gas ratio would need to fall to 6-7x to flatten cost curve; sees 12-15% range ahead.

Calendar 2025 Q2

what sort of sequential lift should we be triangulating based on current visibility? And does anything in your view, support additional price increases that are out in the market

Show response

Peter quantified $85M sequential tailwind from Channelview turnaround completion. Guided 85% segment utilization for Q3. Kim added that back-to-back PE price increases are historically unusual without supply disruption, but cited several positive indicators: improving exports, domestic demand up YoY/QoQ/MoM, low global inventories, and hurricane season risk.

Calendar 2025 Q1

why is now the right time to proceed? And would you consider delaying if negative conditions persist

ChallengingCapex InvestmentCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Peter defended Flex-2 timing citing mid-teens IRR. VEP and cash improvement plan enable continued strategic investment. Committed that 2026 CapEx will not be substantially higher than 2025 levels. Strategy confirmed even in volatile environment.

Calendar 2024 Q4

sitting with plenty of supply overhang across a number of chains, sluggish demand, does anything suggest this is the new normal

ChallengingDemandCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Peter acknowledged structural shifts moderating future mid-cycle margins but pointed to demand recovery signs. Cited PE domestic demand +4% and overall +8% YoY. Did not directly address whether current margins are the new normal.

SHWThe Sherwin-Williams Company7 questions · 7 reporting periods · 1 of 7 challenging
SHW company page →

Calendar 2026 Q2

give a little bit of detail behind the drivers for both the commercial and protective segments.

DemandRevenue GrowthTranscript · FY2026 Q2 →
Show response

Jaye credited two years of targeted commercial share work and named data centers, semiconductor fabs, water treatment and pharma as Protective drivers.

Calendar 2026 Q1

Have you seen any evidence of weakness quarter to date in order books

DemandSupply ChainTranscript · FY2026 Q1 →
Show response

Heidi said no material order shift. Ben noted 60-90 day feedstock gap from Middle East could squeeze Asia and Europe supply later, potentially impacting demand as costs rise.

Calendar 2025 Q4

given the recent mega merger announcement, there's potentially some fresh disruption.

Competitive DynamicsM&ATranscript · FY2025 Q4 →
Show response

Heidi cited SHW's stable strategy and execution playbook as a competitive advantage during industry disruption; teams will be aggressive.

Calendar 2025 Q3

Can you help square the negative operating leverage despite the positive sales? Maybe just some color around the mix drag

ChallengingMarginGeographic ExpansionTranscript · FY2025 Q3 →
Show response

Al attributed PCG margin decline to unfavorable region/business mix; Europe acquisitions dilutive, Latin America down; Q4 expected to see moderation.

Calendar 2025 Q2

Can you comment on how underlying backlogs and activity, you know, evolved throughout the balance of the quarter and into July.

DemandCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Heidi said res repaint backlogs are stable with marginal bid activity increase; project sizes getting smaller; SHW working with contractors to find new opportunities and positioned to win when market recovers.

Calendar 2025 Q1

Just on the continued strength in res repay, can you comment on underlying market trends, backlogs and any concerns with pressure on the consumer

DemandCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Heidi characterized res repaint backlogs as positive with smaller project sizes; SHW investing in SG&A ahead of the curve to capture share; labor/immigration not a concern given value prop focused on productivity.

Calendar 2024 Q4

I'm curious on the latest thoughts on the M&A pipeline.

M&ACapital AllocationTranscript · FY2024 Q4 →
Show response

Heidi described M&A as a consistent steady-hand approach, always looking for technology/brand/region opportunities but not dependent on it for growth; will evaluate attractive opportunities that fit strategy.

CTVACorteva6 questions · 6 reporting periods · 0 of 6 challenging
CTVA company page →

Calendar 2026 Q2

How should we think about your normalized free cash flow levels maybe next year

Capital AllocationGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Johnson said ex-unusual items free cash flow conversion would be around 46%, within the 45-50% of EBITDA midterm target.

Calendar 2026 Q1

What is the target percentage for this mix by the end of the decade?

Competitive DynamicsInnovation & R&DTranscript · FY2026 Q1 →
Show response

Robert King noted portfolio is roughly two-thirds differentiated with new CP products pushing $2B in revenue. Rinskor, Aviso for Asian soybean rust, and biologicals will drive further mix improvement. Did not directly address patent cliffs.

Calendar 2025 Q4

does the current channel inventory position support a return to more normalized purchasing patterns?

Show response

Robert said channels about normal for time of year. Expecting continued volume growth in LatAm with more land in production but pricing pressures to persist. Farmers stressed with high interest rates and suppressed commodity prices but still making money. Barter program near $1B in combined crop and seed revenue to mitigate risk.

Calendar 2025 Q3

Could you provide an update on hybrid wheat or double cropping systems

Innovation & R&DProduct LaunchTranscript · FY2025 Q3 →
Show response

Chuck confirmed 2027 hybrid wheat launch on track. Seeing 10-15% consistent yield improvement in year 3 of trials. $1B peak revenue potential. Margin profile expected similar to corn/soybeans.

Calendar 2025 Q2

how sizable has that benefit been in the first half of '25? And should that still be a sizable benefit in 2026

Cost PressureMarginTranscript · FY2025 Q2 →
Show response

David said slightly ahead on seed net cost improvement. Commodity impact runs through P&L over 2-3 year period via hedges and inventory. $700M 3-year target tracking well.

Calendar 2025 Q1

Seed production costs were solidly lower in the quarter and just want to understand the extent of commodity cost inflation hitting the P&L versus execution on productivity

Cost PressureMarginTranscript · FY2025 Q1 →
Show response

Judd said $100M cost benefit in Q1 split between commodity and productivity. David confirmed $200M seed and $200M CP for full year, with H1 somewhat front-loaded due to deflation timing.

Show 5 more companies
ECLEcolab6 questions · 6 reporting periods · 1 of 6 challenging
ECL company page →

Calendar 2026 Q2

can you share details on what is contributing to the increased traction there? And how much acceleration do you expect

Revenue GrowthDemandCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Beck credited the One Ecolab cross-sell of food safety into water customers and vice versa, noting F&B sits at the top of its 5% to 7% long-term target range with global rollout still ahead.

Calendar 2026 Q1

is most of your growth coming from deeper penetration of digital suites and productivity tools

Innovation & R&DCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Beck confirmed digital-led growth in Specialty at 9%. Emphasized wherever the consumer goes, Ecolab captures them across luxury, mid-scale, or quick-serve.

Calendar 2025 Q4

you maybe give us an update on how your ability to monetize these technologies has evolved in 2025

Innovation & R&DRevenue GrowthTranscript · FY2025 Q4 →
Show response

Beck described Ecolab Digital at ~$400M growing 20%+ in 2025, expects ~25% growth in 2026. Vision is 100-1-100: 100% locations connected, 100% applications, 100% billable. Many customers using technology but not yet paying. Low single-digit penetration with millions of potential customers.

Calendar 2025 Q3

How should we think about SG&A leverage, particularly in Pest and Life Sciences, next year as you start to lap some of the growth investments you've made across both businesses?

MarginCapex InvestmentTranscript · FY2025 Q3 →
Show response

Kirkland reported 150bps SG&A leverage since 2019, expects 20-30bps in FY2025. Beyond 2025, expects 25-50bps annual SG&A leverage from One Ecolab savings and technology deployment. Beck highlighted AI agents driving productivity.

Calendar 2025 Q2

I think you cited supply chain costs and unfavorable mix. But I think our assumption was some of these faster-growing markets have better mix. So what was the source of that unfavorable mix?

ChallengingMarginDemandTranscript · FY2025 Q2 →
Show response

Kirkland attributed all Water OI drag to basic industries and paper. Ex those businesses, Water grew 4% with strong double-digit OI growth.

Calendar 2025 Q1

What sort of growth rates and margin accretion are you anticipating?

Innovation & R&DMarginTranscript · FY2025 Q1 →
Show response

Beck declined to disclose margin yet but noted very high margins given digital nature. Software growing faster than hardware. 100K connected of 1M+ potential.

LINLinde plc6 questions · 5 reporting periods · 0 of 6 challenging
LIN company page →

Calendar 2026 Q2

is the bulk of that inflection that you have seen coming from commercial space?

DemandMacroeconomicTranscript · FY2026 Q2 →
Show response

Sanjiv gave a detailed second-half end-market outlook, citing 18% electronics growth, robust manufacturing, and spottier chemicals/energy.

Calendar 2026 Q1

it seems like there's probably a heightened focus on energy security, deglobalization -- so I'm curious as how you're thinking about the potential

MacroeconomicCapex InvestmentTranscript · FY2026 Q1 →
Show response

White said renewables still require government support to accelerate. Traditional hydrocarbons like Canadian oil sands getting renewed interest given lower exploration risk. Expects more LNG development in stable geographies.

how should we think about on-site volumes and potential earnings upside for the balance of the year

DemandMacroeconomicTranscript · FY2026 Q1 →
Show response

White acknowledged some assets running well but production shifting to Americas. European recovery needs a catalyst, either import restrictions or IAA spending reaching the ground. Hard to see major shift without policy change.

Calendar 2025 Q4

on the 90 new customer wins in oxyfuel combustion, can you just help us understand the specific customer base

DemandInnovation & R&DTranscript · FY2025 Q4 →
Show response

Sanjiv highlighted oxyfuel wins globally with China disproportionately high. Technology helps customers reduce emissions, lower natural gas consumption, and increase throughput. Business development momentum playing out with wins under execution.

Calendar 2025 Q3

it seems like we've lapped some of the tariff concerns, you started to see some uptick here

DemandTrade TariffsTranscript · FY2025 Q3 →
Show response

Sanjiv detailed US package: mid-single digit organic growth, gas volumes down low single digit (helium drag), hard goods up mid-single digit from automation/equipment. Customer sentiment cautious on major CapEx but volumes resilient.

Calendar 2024 Q4

Just on the step-up in CapEx for 2025, is most of that being driven by the two large projects?

Show response

Sanjiv confirmed backlog driving CapEx step-up including two large clean energy projects and electronics projects.

PPGPPG Industries6 questions · 6 reporting periods · 0 of 6 challenging
PPG company page →

Calendar 2026 Q1

you mentioned closing 4 manufacturing plants in the second half. Could you quantify the fixed cost savings there

Cost PressureMarginTranscript · FY2026 Q1 →
Show response

Knavish: 4 plant closures yield approximately $25 million annual fixed cost reduction starting 2027 in perpetuity. Total company restructuring benefits about $50 million in 2026 and another $50 million in 2027 including back-office and formula optimization. Arch EMEA mission: deliver good earnings and cash at flat volumes to fund higher-growth businesses. Had a good March. Not waiting for recovery, building a business that performs at flat volumes. Constantly evaluating each business's mission in portfolio.

Calendar 2025 Q4

You seem to call out normalization to industry growth rates. It seems like you still have some nice marine products that are ramping up

Competitive DynamicsDemandTranscript · FY2025 Q4 →
Show response

Morales attributed PMC normalization to difficult comparables (11 consecutive quarters compounding) and project-based business requiring new project wins. No share losses implied. Knavish highlighted marine aftermarket strength (SigmaGlide technology) and Asia new builds.

Calendar 2025 Q3

you've previously quantified some of the industrial share gains at $100 million. I guess, first, is that still tracking to plan?

Competitive DynamicsMarginTranscript · FY2025 Q3 →
Show response

Morales emphasized volume leverage on fixed costs as biggest earnings lever. Knavish confirmed $100M all flowing through; additional wins above that being won throughout 2025 for longer-term launch. Won't fully offset H1 2026 macro/refinish headwinds but positions well for midterm.

Calendar 2025 Q2

Aerospace continues to be quite strong over a 2- or 3-year stack. How should we think about growth levels over the next few years

Revenue GrowthCapex InvestmentTranscript · FY2025 Q2 →
Show response

Knavish bullish on all aerospace segments with CEO-level connections confirming extremely strong forecasts. Just announced new $380M aerospace factory in the U.S. Continued debottlenecking investments. No end in sight to growth trajectory.

Calendar 2025 Q1

Just on the Industrial Coatings subsegment within Industrial, you had positive volumes in the quarter. How meaningful were share gains here? And was there any evidence of some prebuying impact that...

Competitive DynamicsDemandTranscript · FY2025 Q1 →
Show response

Knavish emphasized momentum from share gains won throughout 2024 into early 2025 now launching. Growth in China, India, general finishes, and U.S. industrial coatings. Used word 'momentum' repeatedly to characterize the trajectory.

Calendar 2024 Q4

what do you see as some of the catalysts to get consumer confidence off the bottom here

DemandMacroeconomicTranscript · FY2024 Q4 →
Show response

Knavish cited easing inflation, potential rate cuts, and stabilization after 5 years of decline. Morales noted sequential stabilization from mid-single-digit decline in 2023 to flat in H2 2024.

DOWDow Inc.4 questions · 4 reporting periods · 0 of 4 challenging
DOW company page →

Calendar 2026 Q1

Could you perhaps walk through any impacts of the conflict on maybe the 10% to 15% of non-polyolefin derivatives that are exposed to some of these tightening market dynamics

Supply ChainDemandTranscript · FY2026 Q1 →
Show response

Fitterling said MEG biggest impact; Equate's global footprint (Canada/Texas) offsetting Kuwait shutdown. Polypropylene less impacted due to weak downstream demand in autos/appliances. Carter noted silicones/siloxanes seeing price increases from China anti-involution rather than conflict.

Calendar 2025 Q3

can you help quantify the run rate earnings contribution from some of these growth investments?

Capex InvestmentMarginTranscript · FY2025 Q3 →
Show response

Carter said Poly-7 and alkoxylation combined $100-200M annualized; ~$40M delivered in Q3. Fitterling added now ethylene-balanced, capturing full integrated margin.

Calendar 2025 Q2

do you see any need for further portfolio restructuring actions on your JVs?

Capital AllocationTranscript · FY2025 Q2 →
Show response

Fitterling said equity earnings depressed by same market conditions. Kuwait and Thailand in good shape. Active refinancing work on Sadara with Aramco before grace period ends.

Calendar 2024 Q4

are China oversupply issues getting better or worse into 2025? And with the focus on more downstream specialties, would you anticipate taking any further actions on upstream assets

Supply ChainCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Fitterling said improving slowly. Carter added downstream growing above GDP in electronics and personal care, while upstream capacity additions from China 2022-2023 have slowed.

IFFInternational Flavors & Fragrances4 questions · 4 reporting periods · 0 of 4 challenging
IFF company page →

Calendar 2026 Q2

your current outlook for input cost inflation in the second half and whether or not you're encountering any pricing lag or customer resistance

Cost PressurePricingTranscript · FY2026 Q2 →
Show response

DeVeau expects input costs to rise modestly in H2 with Scent most impacted; IFF is implementing customer surcharges with some lag while pushing productivity to protect EBITDA margins.

Calendar 2025 Q4

could you comment on any early interest in the sale? Were there any inbounds prior to the formal process?

M&ACapital AllocationTranscript · FY2025 Q4 →
Show response

Erik confirmed strong early inbound interest from both strategics and PE, with additional firms expressing interest since formal launch. Proceeds earmarked for share buybacks to offset dilution and debt paydown to maintain sub-3x leverage.

Calendar 2025 Q2

On the divestiture to Bunge, can you walk through the strategic rationale? Any dissynergies that you see and help us size the business from a margin perspective?

Show response

Erik explained the divestiture removes commoditized soy crush, concentrates and lecithin with low single-digit EBITDA margins, improving Food Ingredients margins and enabling focus on differentiated isolated soy protein.

Calendar 2025 Q1

what drove volumes lower in protein solutions and how should we think about the outlook there and overall food ingredient volumes for the year

Show response

Erik detailed protein weakness from lower-value segment softness and production issues now being resolved. Food Ingredients EBITDA margins progressed from 12% to 13.9%.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
APD Air Products1315%2 of 13 questions
DD DuPont90%none of 9 questions
ALB Albemarle Corporation714%1 of 7 questions
LYB LyondellBasell729%2 of 7 questions
SHW The Sherwin-Williams Company714%1 of 7 questions
CTVA Corteva60%none of 6 questions
ECL Ecolab617%1 of 6 questions
LIN Linde plc60%none of 6 questions
PPG PPG Industries60%none of 6 questions
DOW Dow Inc.40%none of 4 questions
  • APD
    Air Products · 13 questions
    15%2 of 13 questions
  • DD
    DuPont · 9 questions
    0%none of 9 questions
  • ALB
    Albemarle Corporation · 7 questions
    14%1 of 7 questions
  • LYB
    LyondellBasell · 7 questions
    29%2 of 7 questions
  • SHW
    The Sherwin-Williams Company · 7 questions
    14%1 of 7 questions
  • CTVA
    Corteva · 6 questions
    0%none of 6 questions
  • ECL
    Ecolab · 6 questions
    17%1 of 6 questions
  • LIN
    Linde plc · 6 questions
    0%none of 6 questions
  • PPG
    PPG Industries · 6 questions
    0%none of 6 questions
  • DOW
    Dow Inc. · 4 questions
    0%none of 4 questions
Show all 11 companies
CompanyQuestionsChallenge rate
IFF International Flavors & Fragrances40%none of 4 questions
  • IFF
    International Flavors & Fragrances · 4 questions
    0%none of 4 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q320%none of 2 questions1
2024 Q41010%1 of 10 questions8
2025 Q11020%2 of 10 questions8
2025 Q21010%1 of 10 questions9
2025 Q3119%1 of 11 questions9
2025 Q490%none of 9 questions8
2026 Q11414%2 of 14 questions10
2026 Q290%none of 9 questions9
  1. 2024 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
  2. 2024 Q410 questions · challenge rate 10% (1 of 10 questions) · 8 companies
  3. 2025 Q110 questions · challenge rate 20% (2 of 10 questions) · 8 companies
  4. 2025 Q210 questions · challenge rate 10% (1 of 10 questions) · 9 companies
  5. 2025 Q311 questions · challenge rate 9% (1 of 11 questions) · 9 companies
  6. 2025 Q49 questions · challenge rate 0% (none of 9 questions) · 8 companies
  7. 2026 Q114 questions · challenge rate 14% (2 of 14 questions) · 10 companies
  8. 2026 Q29 questions · challenge rate 0% (none of 9 questions) · 9 companies

Topics

Topics tagged on this analyst’s questions.

  • Demand25
  • Margin20
  • Competitive Dynamics18
  • Capex Investment16
  • Capital Allocation8
  • Pricing8
  • Supply Chain7
  • Innovation & R&D7
  • Regulation Policy6
  • Revenue Growth6
Show all 20 topics
  • Cost Pressure5
  • Macroeconomic5
  • M&A5
  • Trade Tariffs3
  • Geographic Expansion2
  • Guidance Reliability1
  • Inventory1
  • Credit1
  • Product Launch1
  • Cloud & AI1